Host Dr. Matt Birnholz talks with Dr. James Watson, winner of the 1962 Nobel Prize for the discovery of the structure of DNA. They discuss Dr. Watson's current and most pressing interest in cancer research, and its biochemical causes. Also, blogger and physician technologist Dr. Joseph Kim joins Drs Michael Greenberg and Matt Birnholz to talk about Apple's new iPad and its potential uses in healthcare. Dr. Kim is the author of several blogs, including Medicine and Technology. And in the Forum, Greenberg and Birnholz discuss the Lancet retraction of the MMR vaccine and autism link research.
Searching for a Cure for Cancer: James Watson, Discoverer of DNA

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Host Dr. Matt Birnholz talks with Dr. James Watson, winner of the 1962 Nobel Prize for the discovery of the structure of DNA. They discuss Dr. Watson's current and most pressing interest in cancer research, and its biochemical causes. Also, blogger and physician technologist Dr. Joseph Kim joins Drs Michael Greenberg and Matt Birnholz to talk about Apple's new iPad and its potential uses in healthcare. Dr. Kim is the author of several blogs, including Medicine and Technology. And in the Forum, Greenberg and Birnholz discuss the Lancet retraction of the MMR vaccine and autism link research.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?